ArticleBMJ open2022

Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis.

Xuemei Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.